Board Moves January 3, 2023

Krista Bates has resigned as non-executive director of AusCann Group Holdings following the completion of a 3-year term on the board.

Austal has appointed Lee Goddard as non-executive director. Mr Goddard had a distinguished full-time naval career in the Royal Australian Navy for 34 years, concluding his tenure in 2021 as a Rear Admiral. He is currently an executive director and chief executive of the Australian Missile Corporation.

Buru Energy has appointed current executive chair Eric Streitberg as non-executive chair. Mr Streitberg has been a director of the company since its formation via a demerger from ARC Energy subsequent to its takeover by AWE Limited in 2008, becoming executive chair in 2014. 

Australian managed services and IT solutions company Cirrus Networks has appointed Kelly Moore and Michelle Kennedy as joint company secretaries, taking over from Catherine Anderson who has resigned after 12.5 years with the company. Ms Moore and Ms Kennedy are both qualified Chartered Accountants, and Ms Moore is also a qualified Company Secretary, with extensive experience in providing accounting and secretarial advice to public companies.

Scott Mathewson has resigned as a director of Golden Deeps. He has been a consultant and a director since April 2020.

Leo Lithium has appointed experienced mining executive Alan Rule as non-executive director. Mr Rule has more than 25 years of experience as the chief financial officer of ASX-listed mining companies with operations and projects in Australia, Africa, North and South America across several commodities, including lithium. He also has considerable experience in international debt and equity financing of mining projects, implementation of accounting controls and systems, risk management, governance, regulatory requirements and mergers & acquisitions within the mining industry.

Michael Fry has taken over from Susan Park as company secretary of Lindian Resources. Mr Fry has over 30 years of experience in the corporate finance industry as a company secretary, chief financial officer and director of ASX-listed companies.

Evan Hayes has resigned as a non-executive director of MGC Pharmaceuticals, as part of the company’s transition to a dedicated European-based life sciences pharmaceuticals company.